NCT01580371View on ClinicalTrials.gov

Safety and Pharmacokinetic Profile of CKD-581

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions
LymphomaMultiple Myeloma
Interventions
DRUG

CKD-581

CKD-581 qd for Day 1, 8 and 15 every 28days/Cycle

Trial Locations (1)

Unknown

ASAN Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01580371 - Safety and Pharmacokinetic Profile of CKD-581 | Biotech Hunter | Biotech Hunter